effect of sodium metavanadate supplementation on lipid and glucose levels in type 2 diabetic patients refered to yazd diabetes research center in summer 2007
Clicks: 123
ID: 220866
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
123 views
10 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #63 of 69 articles by views in journal of consulting and clinical psychology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
<p><strong>Background and Objective</strong></p><p>Type 2 diabetes mellitus is a chronic, progressive illness that causes considerable morbidity and mortality. Despite recent technical advances in therapy, more people are using alternative therapies. In this study evaluated the effect of sodium metavanadate on glucose levels and lipid profile in type 2 diabetes mellitus patients.</p><p><strong> </strong></p><p><strong>Methods</strong></p><p>This is a randomized, controlled trial study. Forty subjects admitted to Yazd Diabetes Research Center, Yazd, Iran were divided randomly into two groups and supplemented daily with 100 mg sodium metavanadate or placebo for six weeks. Body Mass Index (BMI), Blood Pressure and Fasting Blood Sugar (FBS), 2-h postprandial glucose( 2hpp), Glycated hemoglobin (HbA1C), Triglyceride (TG), cholesterol (chol), low-density lipoproteins ( LDL), high-density lipoproteins (HDL), Blood Urea Nitrogen( BUN ), Creatinin (Cr), Alanine aminotransferases (ALT), Aspartate aminotransferases(AST) were assayed before and after 6 weeks sodium metavanadate supplementation. HbA1C, BMI and blood pressure also were analyzed in 12<sup>th</sup> week to evaluate the long term effect of drugs.</p><p><strong> </strong></p><p><strong>Results</strong></p><p>Thirty eight patients with mean age of 53.10±8.48 years old were included in the study. Although FBS, HbA1C, Cholesterol and LDL levels decreased after six weeks supplementation but it was not statistically significant. However a significant decrease occurred in TG levels (P=0.01) and BMI (p=0.03). After 12 weeks, there was a significant decrease in BMI (P=0.01).</p><p><strong> </strong></p><p><strong>Conclusion</strong></p><p>It is recommended to test another vanadium compound in type 2 diabetic patients to achieve better results.</p>
| Reference Key |
afkhami2012majallah-ieffect
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;M Afkhami |
| Journal | journal of consulting and clinical psychology |
| Year | 2012 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.